Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2010 Oct 15;20(20):6067-71. Epub 2010 Aug 13.

    Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases.

    Source

    Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA. gary.t.wang@abbott.com

    Abstract

    This Letter describes the lead discovery, optimization, and biological characterization of a series of substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as potent inhibitors of IGF1R, EGFR, and ErbB2. The leading compound 11 showed an IGF1R IC(50) of 12 nM, an EGFR (L858R) IC(50) of 31 nM, and an ErbB2 IC(50) of 11 nM, potent activity in cellular functional and anti-proliferation assays, as well as activity in an in vivo pharmacodynamic assay.

    Copyright © 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20817523
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk